ガイドライン

(旧版)科学的根拠に基づく急性胆管炎・胆嚢炎の診療ガイドライン

書誌情報
 
第VI章 急性胆管炎 -基本的治療-


引用文献
1) Lillemoe KD. Surgical treatment of biliary tract infections. Amer Surgeon 2000 ; 66 : 138-44.(治療レベル4)
2) Siever W, Vakil NB. Emergency of the biliary tract. Gastroenterol Clin North Amer 1988 ; 17 : 245-64.(治療レベル4)
3) Kadakia SC. Biliary tract emergencies. Acute cholecystitis, acute cholangitis, and pancreatitis. Med Clin North Am 1993 ; 77 : 1015-35.(治療レベル4)
4) Hanau LH, Steigbigel NH. Acute (ascending) cholangitis. Infect Dis Clin North Amer 2000 ; 14 : 521-46.(治療レベル4)
5) Cohen SA, Siegel JH. Endoscopic and medical management. Crit Care Clin 1995 ; 11 : 273-94.(治療レベル4)
6) Pitt HA, Postier RG, Cameron JL. Consequences of preoperative cholangitis and its treatment on the outcome of operation for choledocholithiasis. Surgery 1983 ; 94 : 447-52.(診断レベル2b)
7) Maluenda F, Csendes A, Burdiles P, Diaz J. Bacteriological study of choledochal bile in patients with common bile duct stones, with or without acute suppurative cholangitis. Hepato-Gastroenterol 1989 ; 36 : 132-5.(診断レベル3b)
8) Claesson BE. Microflora of the biliary tree and liver‐clinical correlates. Digest Dis 1986 ; 4 : 93-118.(診断レベル5)
9) Marne C, Pallares R, Martin R, Sitges-Serra A. Gangrenous cholecystlithiasis and acute cholangitis associated with anaerobic bacteria in bile. Eur J Clin Microbiol 1986 ; 5 : 35-9.(診断レベル3b)
10) Hanau LH, Steigbigel NH : Cholangitis. pathogenesis, diagnosis, and treatment. Curr Clin Topics in Infect Dis 1995 ; 15 : 153-78.(診断レベル5)
11) Hanau LH, Steigbigel NH. Acute (ascending) cholangitis. Infect Dis Clin North Amer 2000 ; 14 : 521-46.(診断レベル5)
12) Westphal JF, Brogard JM. Biliary tract infections : a guide to drug treatment. Drugs 1999 ; 57 : 81-91.(診断レベル5)
13) Sinanan MN. Acute cholangitis. Infect Dis Clin North Amer 1992 ; 6 : 571-99.(診断レベル5)
14) Thompson J, Bennion RS, Pitt HA. An analysis of infectious failures in acute cholangitis. HPB Surg 1994 ; 8 : 139-44.(診断レベル4)
15) Csendes A, Burdiles P, Maluenda F, Diaz JC, Csendes P, Mitru N. Simultaneous bacteriologic assessment of bile from gallbladder and common bile duct in control subjects and patients with gallstones and common duct stones. Arch Surg 1996 ; 131 : 389-94.(診断レベル2b)
16) Csendes A, Mitru N, Maluenda F, Diaz JC, Burdiles P, Csendes P, et al Counts of bacteria and pyocites of choledochal bile in controls and in patients with gallstones or common bile duct stones with or without acute cholangitis. Hepato-Gastroenterol 1996 ; 43 : 800-6.(診断レベル2b)
17) Csendes A, Becerra M, Burdiles P, Demian I, Bancalari K, Csendes P. Bacteriological studies of bile from the gallbladder in patients with carcinoma of the gallbladder, cholelithiasis, common bile duct stones and no gallstones disease. Eur J Surg 1994 ; 160 : 363-7.(診断レベル2b)
18) Csendes A, Fernandez M, Uribe P. Bacteriology of the gallbladder bile in normal subjects. Am J Surg 1975 ; 129 : 629-31.(診断レベル3b)
19) Kune GA, Schutz E. Bacteria in the billary tract. A study of their frequency and type. Med J Australia 1974 ; 1 : 255-8.(診断レベル3b)
20) Chang WT, Lee KT, Wang SR, Chuang SC, Kuo KK, Chen JS, et al. Bacteriology and antimicrobial susceptibility in biliary tract disease : an audit of 10-year's experience. Kaohsiung J Med Sciences 2002 ; 18 : 221-8.(診断レベル3b)
21) 三浦則正,大野昭二,高相 進.胆石症における胆汁内細菌の検討.大田総合病院年報 1987 : 67-72.(診断レベル4)
22) Brismar B, Jalakas K, Malmborg AS. The significance of bacteriological findings at cholecystectomy. Acta Chir Scand 1986 ; 530 suppl : 35-8.(診断レベル3b)
23) Jarvinen HJ. Biliary bacteremia at various stages of acute cholecystitis. Acta Chir Scand 1980 ; 146 : 427-30.(診断レベル3b)
24) Claesson BE, Holmlund DE, Matzsch TW. Microflora of the gallbladder related to duration of acute cholecystitis. Surg Gynecol Obstet 1986 ; 162 : 531-5.(診断レベル 2b)
25) Nielsen ML, Justesen T. Anaerobic and aerobic bacteriological studies in biliary tract disease. Scand J Gastroenterol 1976 ; 11 : 437-46.(診断レベル3b)
26) Flinn WR, Olson DF, Oyasu R, Beal JM. Biliary bacterial and hepatic histopathologic changes in gallstone disease. Ann Surg 1977 ; 185 : 593-7.(診断レベル3b)
27) Csendes A, Hurdiles P, Diaz JC, Maluenda F, Ferrario M, Compan A. Bacteriological studies of liver parenchyma in controls and in patients with gallstones or common bile duct stones with or without acute cholangitis. Hepato Gastroenterol 1995 ; 42 : 821-6.(診断レベル2b)
28) den Hoed PT, Boelhouwer RU, Veen HF, Hop WC, Bruining HA. Infections and bacteriological data after laparoscopic and open gallbladder surgery. J Hosp infec 1998 ; 39 : 27-37.(診断レベル3b)
29) Chaitin H. Bacteriology of Calculous Choelcystitis. Int Surg 1973 ; 58 : 169-70.(診断レベル3b)
30) Truedoson H, Elmros T, Holm S. Elective cholecystectomy with intraperitoneal drain. A bacteriological evaluation. Acta Chir Scand 1983 ; 149 : 315-21.(診断レベル3b)
31) Truedson H, Elmors T, Holms S. The incidence of bacteria in gallbladder bile at acute and elective cholecystectomy. Acta Chir Scand 1983 ; 149 : 307-13.(診断レベル3b)
32) Keighley MR, Flinn R, Alexander-Williams J. Multivaliate analysis of clinical and operative findings associated with biliary sepsis. Brit J Surg 1976 ; 63 : 528-31.(診断レベル3b)
33) Tabata M, Nakayama F. Bacteriology of hepatolithiasis. Prog in Clin Biol Res 1984 ; 152 : 163-74.(診断レベル5)
34) Gerecht WB, Henry NK, Hoffman WW, Muller SM, LaRusso NF, Rosenblatt JE, et al. Prospective randomized comparison of mezlocillin therapy alone with combined ampicillin and gentamicin therapy for patients with cholangitis. Arch Intern Med 1989 ; 149 : 1279-84.(治療レベル2b)
35) Muller EL, Pitt HA, Thompson JE Jr, Doty JE, Mann LL, Manchester B. Antibiotics in infections of the biliary tract. Surg Gynecol Obstet 1987 ; 165 : 285-92.(治療レベル2b)
36) Thompson JE Jr, Pitt HA, Doty JE, Coleman J, Irving C. Broad spectrum penicillin as an adequate therapy for acute cholangitis. Surg Gynecol Obstet 1990 ; 171 : 275-82.(治療レベル2b)
37) Thompson JE Jr, Bennion RS, Roettger R, Lally KP, Hopkins JA, Wilson SE. Cefepime for infections of the biliary tract. Surg Gynecol Obstet 1993 ; 177 Suppl : 30-4.(治療レベル2b)
38) Sung JJ, Lyon DJ, Suen R, Chung SC, Co AL, Cheng AF, et al. Intravenous ciprofloxacin as treatment for patients with acute suppurative cholangitis : a randomized, controlled clinical trial. J Antimicrob Chemother 1995 ; 35 : 855-64.(治療レベル2b)
39) Gilbert D, Moellering R Jr, Eliopoulos GM, Sande M. The Sanford Guide to antimicrobial therapy. 35rd ed. Hyde Park, VT : Antimicrobial Therapy, Inc, 2005.(治療レベル3)
40) Leung JW, Chan CY, Lai CW, Ko TC, Cheng AF, French GL. Effect of biliary obstruction on the hepatic excretion of imipenem-cilastatin. Antimicrob Agents Chemother 1992 ; 36 : 2057-60.(治療レベル3b)
41) 谷村 弘,斉藤 徹,関谷 司,小林展章,日笠頼則.胆道感染症の化学療法(XIV)-Piperacillinの胆汁中移行と胆嚢組織濃度.Jpn J Antibiot 1981 ; 34 : 1401-9.(治療レベル4)
42) 谷村 弘,斎藤 徹,小林展章.胆道感染症の化学療法(XIX)TA-058の胆汁中移行とその臨床効果について.Chemotherapy 1984 ; 32 Suppl 2 : 502-13.(治療レベル4)
43) 品川長夫,由良二郎,真下啓二,松野正紀,力山 敏,平山 隆,他.外科領域感染症におけるTazobactam/ Piparacilinの基礎的・臨床的評価.Jpn J Antibiot 1995 ; 48 : 346-67.
44) 田村 隆,加藤 彰,中島幹夫.Cefazolinの胆汁中移行について.日臨外会誌 1982 ; 43 : 1325-8.(治療レベル4)
45) 葛西洋一,中西昌美,沢田康夫,中村 孝,橋本伊久雄,三上二郎,他.Cefmetazolの臨床的研究-特に胆道系疾患について.Jpn J Antibiot 1979 ; 32 : 606-11.(治療レベル4)
46) 西村興亜,河野菊弘,澄川 学,河村良寛,日前敏子,小立寿成,他.Cefotiamの胆汁中並びに胆嚢組織内移行に関する臨床的検討.Jpn J Antibiot 1984 ; 37 : 219-28.(治療レベル4)
47) 谷村 弘,小林展章,斎藤 徹,黄 文芳,吉田圭介,高橋 裕,他.胆道感染症の化学療法(209)6315-S(Flomoxef)の胆嚢組織内濃度,胆汁中移行および臨床効果について.Chemotherapy 1987 ; 35 (Suppl 1) : 852-73.(治療レベル4)
48) Leung JW, Ling TK, Chan RC, Cheung SW, Lai CW, Sung JJ, et al. Antibiotics, biliary sepsis, and bile duct stones. Gastrointest Endosc 1994 ; 40 : 716-21.(治療レベル3b)
49) Orda R, Berger SA, Levy Y, Shnaker A, Gorea A. Penetration of ceftriaxone and cefoperazone into bile and gallbladder tissue in patients with acute chlecystitis. Dig Dis Sci 1992 ; 37 : 1691-3.(治療レベル4)
50) 由良二郎,品川長夫,石川 周,城 義政,柴田純孝,河辺章夫.外科領域におけるCefpirome(CPR)の基礎的・臨床的検討.Chemotherapy 1991 ; 39 (Suppl 1) : 379-85.(治療レベル4)
51) 花谷勇治,福富隆志,横山 勲.外科領域におけるCeftazidimeの基礎的・臨床的検討.Chemotherapy 1983 ; 31 Suppl 3 : 683-90.
52) 由良二郎,品川長夫,石川 周,水野 章,真下啓二,石川正一,他.外科領域におけるCefozopranに関する基礎的・臨床的検討.Chemotherapy 1993 ; 41 : 341-7.(治療レベル4)
53) 谷村 弘,村上浩一,内山和久,福 昭人,平田公一,向谷充宏,他.Pazufloxacin注射薬の外科感染症における臨床効果及び体液・組織移行性の検討.Chemotherapy 1999 ; 7 Suppl 1 : 227-41.
54) Martinez O, Levi J, Devlin R. Biliary excretion of aztreonam in patients with biliary tract disease. Antimicrob Agents Chemother 1984 ; 25 : 358-61.(治療レベル4)
55) 清水武昭,土屋嘉昭,佐藤 攻.Meropenemの胆汁中移行および外科的感染症の臨床的検討.Chemotherapy 1992 ; 40 : 507-13.(治療レベル4)
56) Sales J, Sutcliffe M, O'Grady F. Excretion of clindamycin in the bile of patients with biliary tract disease. Chemotherapy 1973 ; 19 : 11-5.(治療レベル4)
57) Chacon JP, Criscuolo PD, Kobata CM, Ferraro JR, Saad SS, Reis C. Prospective randomized comparison of pefloxacin and ampicillin plus gentamicin in the treatment of bacteriologically proven biliary tract infections. J Antimicrob Chemother 1990 ; 26 (Suppl B) : 167-72.(治療レベル2b)
58) Boey J, Way L. Acute cholangitis. Ann Surg 1980 ; 191 : 264-70.(治療レベル5)
59) Thompson JE Jr, Tompkins RK, Longmire WP. Factors in management of acute cholangitis. Ann Surg 1982 ; 195 : 137-45.(治療レベル4)
60) Cunha B. Antibiotic Essentials. New York, NY : Stony Book, 2002.(治療レベル3)
61) 日本感染症学会,日本化学療法学会.抗菌薬使用の手引き.協和企画,東京,2001.
62) 品川長夫.重症胆管炎の治療方針と抗菌薬の選択.胆と膵 1995 ; 16 : 569-74.(治療レベル5)
63) Investigators of the Piparacilin/Tazobactam intra-abdominal infection study group. Results of the North American Trial of Piparacilin/Tazobactam compared with Clindamycin and Gentamicin in the treatment of severe intra-abdominal infections. Eur J Surg 1994 ; 573 (Suppl) : 61-6.
64) Pitt HA, Roberts R, Johnson WJ. Gentamicin levels in the human biliary tract. J Infect Dis1 1973 ; 27 : 299-302.(治療レベル5)
65) Desai T, Tsang T. Aminoglycoside nephrotoxicity in obstructive jaundice. Am J Med 1988 ; 85 : 47-50.(治療レベル4)
66) 岡本好司,高木 輝,武田成彰,加藤秀典,大里敬一.ビタミンK欠乏性出血症の一例.日静脈経腸栄養研会誌 1989 ; 4 : 348-51.(治療レベル5)
67) 田中明隆,星野 信,早川富博,神谷泰隆,大岩孝幸,山田珠樹,他.EST施行3日後に大量出血を認めたビタミンK欠乏の一例.胆道 1993 ; 7 : 183-7.(治療レベル5)
68) Leung JW, Chan RC, Cheung SW, Sung JY, Chung SC, French GL. The effect of obstruction on the biliary excretion of cefoperazone and ceftazidime. J Antimicrob Chemother 1990 ; 25 : 399-406.(治療レベル4)
69) Blenkharn JI, Habib N, Mok D, John L, McPherson GA, Gibson RN, et al. Decreased biliary excretion of piperacillin after percutaneous relief of extrahepatic obstructive jaundice. Antimicrob Agents Chemother 1985 ; 28 : 778-80.(治療レベル4)
70) van den Hazel SJ, de Vries XH, Speelman P, Dankert J, Tytgat GN, Huibregtse K, et al. Biliary excretion of ciprofloxacin and piperacillin in the obstructed biliary tract. Antimicrob Agents Chemother 1996 ; 40 : 2658-60.(治療レベル4)
71) 高田忠敬,羽生富士夫,福島靖彦,内田靖彦,今泉俊秀,安田秀喜,他.閉塞性黄疸における抗生剤の胆汁内移行に関する検討.日消病会誌 1976 ; 73 : 39-47.(治療レベル4)
72) Levi JU, Martinez OV, Malinin TI, Zeppa R, Livingstone A, Hutson D, et al. Decreased biliary excretion of cefamandole after percutaneous biliary decompression in patients with total common bile duct obstruction. Antimicrob Agents Chemother 1984 ; 26 : 944-6.(治療レベル4)
73) 清水武昭,菅野鑑一郎,吉田奎介,川口英弘.抗生物質の胆汁内移行に関する研究-特に胆汁酸代謝と関連して-.胆汁酸研究の進歩.三好秋馬等編.東洋書店,東京,1984 : 325-33.(治療レベル4)
74) 清水武昭,土屋嘉昭.疾患別化学療法-治療法の選択-,胆道系感染症に対する化学療法.日臨 1990 ; 48 : 95-100.(治療レベル5)

 

書誌情報